cetylpyridinium chloride anhydrous has been researched along with Cognitive Decline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hoang, TD; Kivipelto, M; Palmer, K; Yaffe, K | 1 |
| Abiose, O; Andreasson, KI; Barzilai, N; Budde, J; Channappa, D; Cruchaga, C; Greicius, MD; Guen, Y; Haney, M; He, Z; Henderson, VW; Kim, K; Kohlfeld, P; Lehallier, B; Liu, M; Longo, FM; Maurer, TM; Milman, S; Montgomery, SB; Moran-Losada, P; Mormino, E; Nachun, D; Oh, HS; Pálovics, R; Rutledge, J; Sathyan, S; Sung, YJ; Timsina, J; Urey, DY; Wagner, AD; Wang, L; Weiss, EF; Western, D; Wilson, EN; Wyss-Coray, T; Yang, AC | 1 |
| Kidambi, N; Lee, EE | 1 |
| Lees, B; Mewton, L; Rao, RT | 1 |
| Drew, DA; Fried, L; Gutiérrez, OM; Hoofnagle, A; Ix, JH; Katz, R; Kritchevsky, S; Newman, AB; Sarnak, M; Shlipak, M | 1 |
| Brodaty, H; Crawford, J; Draper, B; Kang, K; Kochan, NA; Lipnicki, DM; Lux, O; Mather, KA; Reppermund, S; Sachdev, PS; Slavin, MJ; Trollor, JN; Wen, W | 1 |
| Annweiler, C; Beauchet, O; Kabeshova, A; Launay, CP; Merjagnan, C | 1 |
| Dale, AM; Desikan, RS; Holland, D; McEvoy, LK | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Cognitive Decline
| Article | Year |
|---|---|
Trials and Treatments for Vascular Brain Health: Risk Factor Modification and Cognitive Outcomes.
Topics: Brain; Cerebrovascular Disorders; Cognitive Dysfunction; COVID-19; Health; Humans; Pandemics; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Stroke; Treatment Outcome | 2022 |
7 other study(ies) available for cetylpyridinium chloride anhydrous and Cognitive Decline
| Article | Year |
|---|---|
Organ aging signatures in the plasma proteome track health and disease.
Topics: Adult; Aging; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Cohort Studies; Disease; Disease Progression; Extracellular Matrix; Health; Heart; Heart Failure; Humans; Machine Learning; Organ Specificity; Proteome; Proteomics; Synapses; Vascular Calcification | 2023 |
Insight into Potential Mechanisms Linking Loneliness and Cognitive Decline: Commentary on "Health Factors as Potential Mediator the Longitudinal Effect of Loneliness on General Cognitive Ability".
Topics: Cognition; Cognitive Dysfunction; Health; Humans; Loneliness; Social Isolation | 2020 |
Lifetime perspective on alcohol and brain health.
Topics: Adolescent; Aged; Alcohol Drinking; Atrophy; Binge Drinking; Brain; Cognitive Dysfunction; Dementia; Female; Health; Humans; Male; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Underage Drinking | 2020 |
Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study.
Topics: Aged; Aging; Body Composition; Cognition; Cognitive Dysfunction; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Health; Humans; Male | 2020 |
Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cognition; Cognitive Dysfunction; Demography; Female; Follow-Up Studies; Health; Humans; Life Style; Male | 2013 |
Quantified self and comprehensive geriatric assessment: older adults are able to evaluate their own health and functional status.
Topics: Aged; Alzheimer Disease; Case-Control Studies; Cognitive Dysfunction; Female; Geriatric Assessment; Health; Humans; Male; Middle Aged; Surveys and Questionnaires | 2014 |
Enrichment and stratification for predementia Alzheimer disease clinical trials.
Topics: Aged; Alzheimer Disease; Atrophy; Case-Control Studies; Clinical Trials as Topic; Cognition; Cognitive Dysfunction; Confidence Intervals; Dementia; Demography; Female; Health; Humans; Magnetic Resonance Imaging; Male; Sample Size | 2012 |